COTY · COTY
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $4.67
Note written ·
Price against the kill line
13.5% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $4.67, on record since 11 November 2026. The shares are up 51.3% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $4.67, about 15% above the 11 November 2026 close and over the 52-week intraday high, would show the shares leading the S&P 500. So would a Consumer Beauty sale with an FY27 outlook at or above FY26 adjusted EBITDA of $846.9M.
Research onlyNot in the portfolio.
Catalyst
Key figures from the filings · Consumer Staples
Quarter to 30 September 2026, filed 5 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 1,555
- Revenue, change on a year (%)
- −1.4
- Gross margin (%)
- 63.3
- Operating margin (%)
- 11.0
- Free cash flow, four quarters ($M)
- 422
- Net cash, cash less debt ($M)
- −2,540
- Enterprise value to sales (×)
- 1.1
- Free-cash-flow yield (%)
- 11.8
All filed numbers
What COTY reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 1,555 | −1.4 | 63.3 | 11.0 |
| first filed | 1,269 | +1.3 | 60.9 | −3.4 |
| first filed | 1,282 | −1.3 | 61.8 | −29.0 |
| first filed | 1,679 | +0.5 | 63.8 | 8.8 |
| first filed | 1,577 | −5.6 | 64.5 | 11.7 |
| first filed | 1,252 | −8.1 | 62.3 | 1.2 |
| Pre-tax income ($M) | 157 |
| Net income ($M) four quarters: −563 | 110 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | +0.7 |
| Operating cash flow ($M) | 603 |
| Capital spending ($M) | 181 |
| Free cash flow ($M) | 422 |
| Cash and short-term investments ($M) | 211 |
| Debt ($M) non-current long-term debt plus current debt | 2,751 |
| Net cash, cash less debt ($M) | −2,540 |
| Deferred revenue ($M) | Not reported |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 704 |
| Inventory ($M) | 875 |
| Shareholders' equity ($M) | 3,107 |
| Market value ($M) | 3,561 |
| Enterprise value, market value plus net debt ($M) | 6,101 |
| Enterprise value to sales (×) | 1.1 |
| Enterprise value to operating income (×) | Not meaningful |
| Price to earnings (×) | Not meaningful |
| Price to book value (×) | 1.1 |
| Free-cash-flow yield (%) | 11.8 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 4.7% of shares outstanding sold short, 8.4 days of average trading to cover, +2.8% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $0 |
| 12 monthsfrom | $213K | $0 |
The thesis
Coty Inc.'s debt reduction and first-quarter beat have carried the shares above every published analyst target. Its earnings are still guided lower, and there is no full-year outlook. The Consumer Beauty strategic review, due by 31 December 2026, and the outlook promised after it decide whether earnings can support the price. Until then, the shares are more likely to lag the S&P 500 than lead it over the next three months.
The first quarter of fiscal 2027 (Q1 FY27, ended 30 September 2026) answered part of the question. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortisation) fell 7% to $274.2M. That was better than the low-teens decline Coty had guided. Financial net debt fell to $2,576.4M from $2,912.1M at 30 June 2026 (Coty release, 4 November 2026).
The price then ran ahead of the business facts. The shares closed at $3.47 on 4 November 2026, the day of the report, and at $4.33 on 10 November 2026. They closed at $4.06 on 11 November 2026. The only company filing since the report is the 10 November 2026 8-K. It records the 5 November 2026 annual meeting and names no new officers. Coty still has an interim CEO.
Bullish and bearish views on COTY INC
The bull case on COTY INC (COTY), in brief: Q1 beat on every headline measure. The bear case: every target sits below the price.
Bull case
- Q1 beat on every headline measure. Sales of $1.555B topped a $1.523B estimate, and adjusted EPS of $0.16 topped a $0.12 estimate (Benzinga, 4 November 2026). Like-for-like sales, which compare businesses owned a year earlier, fell 2%, against guidance for a low-to-mid single-digit decline.
- Leverage is falling. Net debt to adjusted EBITDA was 3.1 times at 30 September 2026, down from 3.4 times at 30 June 2026 (Coty release, 4 November 2026). Finsee's review of the results puts the bank covenant ceiling at 4.0 times.
- Cash flow improved. Q1 free cash flow was $84.6M against $11.2M a year earlier, and management kept its first-half forecast above $300M (Coty release, 4 November 2026).
- Core luxury brands returned to growth. The top six Prestige brands grew 5% like-for-like in Q1 (Coty release, 4 November 2026).
- Brokers are revising toward the price. RBC raised its target to $3.50 from $3 on 6 November 2026, and Barclays raised its target to $3 from $2 on 9 November 2026 (Benzinga; MarketBeat, 9 November 2026).
- The Marc Jacobs licence now runs longer. On 4 November 2026 Coty announced an extension of the Marc Jacobs licence to a 40-year term. It partly offsets the Gucci licence, which ends on 30 June 2027.
Bear case
- Every target sits below the price. Barclays is at $3 with Underweight, RBC at $3.50 with Sector Perform and Citigroup at $3 with Neutral (14 October 2026). MarketBeat's consensus on 9 November 2026 was Reduce, with a $3.35 average target from 1 Buy, 10 Hold and 2 Sell ratings.
- Most of the debt cut was one-off cash. The initial $250M of Gucci proceeds from Kering drove most of the Q1 net debt reduction, alongside $84.6M of free cash flow (Coty release, 4 November 2026).
- Consumer Beauty is barely profitable. Segment adjusted EBITDA fell to $11.7M from $28.5M on revenue of $496.8M (Coty release, 4 November 2026). Analysts quoted by FashionNetwork had already flagged ageing brands as a hurdle to a sale. The weaker profit makes a good price harder to reach.
- Earnings are still declining. Coty guided Q2 adjusted EBITDA down by a high-single-digit percentage. Q1 gross margin fell 120 basis points to 63.3% on freight, materials and obsolescence costs (Coty release, 4 November 2026).
- The share reserve grew by 50 million. At the 5 November 2026 annual meeting, stockholders approved an amended equity incentive plan that adds 50 million Class A shares to its reserve. The vote was 642.4M for and 66.8M against (8-K, 10 November 2026).
- There is no full-year outlook. Management calls FY27 a transition year and ties a broader outlook to the Consumer Beauty review. The price is running ahead of any annual earnings range.
Price setup
The shares closed at $4.06 on 11 November 2026. That is 7.1% below the 52-week intraday high of $4.37, set on 10 November 2026, the day of the $4.33 close. The 52-week closing low was $1.85 on 4 June 2026. Adjusted daily closes show a 47.6% gain over three months, from $2.75 on 13 August 2026.
The 50-day moving average was $3.03 and the 200-day moving average $2.56 at the 11 November 2026 close. The shares sit well above both. The levels the case turns on are the $3.29 close of 27 October 2026, before the Q1 report, and the $3.47 close of 4 November 2026, the day of the report. A return toward those closes would mean the market has given back the post-report move.
The only insider filings since August are Form 4s for 19 October 2026 from three officers: the Chief Legal Officer, the Chief Corporate Affairs Officer and the Group Controller. Each reported option exercises with shares withheld for tax. None reported an open-market purchase or sale.
Catalysts ahead
- ~31 December 2026 (est.): Stated deadline for completing the Consumer Beauty strategic review, with a broader outlook to follow. A named buyer or deal structure is the largest remaining debt-reduction event, and the outlook shows where FY27 earnings land against FY26's $846.9M of adjusted EBITDA.
- ~4 February 2027 (est.): Q2 FY27 results. Tests the $0.16-$0.18 adjusted EPS guide, the high-single-digit EBITDA decline and the first-half free cash flow forecast above $300M.
- 30 June 2027: Last date of the Gucci beauty licence. Starts the FY28 sales and profit step-down management has acknowledged, and tests whether Marc Jacobs and the top Prestige brands can absorb it.
What would change the view
A daily close above $4.67, about 15% above the 11 November 2026 close and over the 52-week intraday high, would show the shares leading the S&P 500. So would a Consumer Beauty sale with an FY27 outlook at or above FY26 adjusted EBITDA of $846.9M.
What it trades with
Coty's recent moves follow its own news more than the market. On 5 November 2026 the Nasdaq fell more than 3% (Benzinga, 5 November 2026), while Coty closed at $3.91, up from $3.47 the session before. Among beauty peers, L'Oréal reported Q3 sales of €11.56B against an €11.23B estimate on 22 October 2026, a firm backdrop for prestige fragrance. The Gucci licence end on 30 June 2027 ties Coty's FY28 profit to its own brand portfolio, whatever category demand does.
The evidence, claim by claim (8)
- Q1 FY27 net revenue was $1,555.2M, down 1% reported and 2% like-for-like; the top six Prestige brands grew 5% like-for-like. Coty Q1 FY27 results release · as of
- Q1 FY27 adjusted EBITDA was $274.2M, down 7% from $296.1M, with a 17.6% margin; gross margin fell 120 basis points to 63.3%. Coty Q1 FY27 results release · as of
- Q1 adjusted EPS was $0.16 against a $0.12 estimate and included a $14.8M equity-swap benefit; sales of $1.555B beat a $1.523B estimate. Benzinga, 4 November 2026; Coty release · as of
- Financial net debt was $2,576.4M at 30 September 2026, with leverage of 3.1x, against $2,912.1M and 3.4x at 30 June 2026. Coty Q1 FY27 results release · as of
- Consumer Beauty net revenue was $496.8M, down 3% like-for-like; segment adjusted EBITDA fell to $11.7M from $28.5M. Coty Q1 FY27 results release · as of
- Q2 FY27 guidance: low-single-digit like-for-like revenue decline, high-single-digit adjusted EBITDA decline, adjusted EPS excluding the swap of $0.16-$0.18 against a $0.16 estimate. Coty release; Benzinga · as of
- Stockholders approved an amended equity incentive plan adding 50 million Class A shares to its reserve; no officer appointment or departure was reported. Coty 8-K filed 10 November 2026 (annual meeting of 5 November 2026) · as of
- Barclays kept Underweight and raised its target to $3 from $2; MarketBeat consensus is Reduce with a $3.35 average target (1 Buy, 10 Hold, 2 Sell). MarketBeat, 9 November 2026 · as of
Sources
- COTY ANNOUNCES FIRST QUARTER FISCAL YEAR 2027 RESULTS · coty.com ·
- SEC EDGAR
- Coty (NYSE:COTY) Given New $3.00 Price Target at Barclays · marketbeat.com ·
- Coty Q1 FY2027 Revenue Falls 1%; Adjusted EPS Rises to $0.16 · tradingview.com
- Coty (COTY) Q1 2027 earnings review · finsee.ai
- Analysts flag ageing brands as a hurdle to Coty's consumer beauty unit sale · uk.fashionnetwork.com
Related · shared themes
CPRI
Capri Holdings
Capri Holdings' Michael Kors turnaround gives the shares a modest edge over the S&P 500 after the 30 October 2026 beat-and-raise, despite a…
CROX
Crocs
Crocs, Inc. is more likely to lead the S&P 500 over three months: a third-quarter beat and a third guidance raise lifted full-year adjusted…
CRSR
Corsair Gaming
Corsair Gaming's recovery case holds after it beat third-quarter guidance and raised its 2026 outlook on 5 November 2026; the…
EL
Estee Lauder Companies
Estée Lauder's turnaround now shows in sales as well as margins, with first-quarter organic sales up 6% and the fiscal 2027 outlook raised…
See also · stocks to watch